Castration-Sensitive Prostate Carcinoma

Oncology
3
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Knight Therapeutics
Knight TherapeuticsQC - Montréal
1 program
1
Abiraterone AcetatePhase 2
Alliance Pharmaceuticals
1 program
1
Pharmacotherapy DiscontinuationPhase 21 trial
Active Trials
NCT05241860Active Not Recruiting79Est. Sep 2033
Xencor
XencorPASADENA, CA
1 program
1
AbirateronePhase 11 trial
Active Trials
NCT05733351Terminated4Est. Jun 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Alliance PharmaceuticalsPharmacotherapy Discontinuation
XencorAbiraterone

Clinical Trials (2)

Total enrollment: 83 patients across 2 trials

NCT05241860Alliance PharmaceuticalsPharmacotherapy Discontinuation

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Start: Nov 2022Est. completion: Sep 203379 patients
Phase 2Active Not Recruiting
NCT05733351XencorAbiraterone

Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Start: Aug 2023Est. completion: Jun 20254 patients
Phase 1Terminated

Related Jobs in Oncology

Summer intern Neuroscience

Arvinas
New Haven - CT
6h ago

Medical Representative - CVRM - HCM

AstraZeneca
Vietnam - Ho Chi Minh City
11h ago

Operator

Sartorius Stedim Biotech
Shanghai
11h ago

Technician, Quality Assurance - Night Shift

Orca Bio
Sacramento, CA
11h ago
$65K - $71K/yr

Supervisor, Materials and Cold Chain Operations - Night Shift

Orca Bio
Sacramento, CA
17h ago
$75K - $95K/yr

Supervisor, Materials and Cold Chain Operations - Day Shift

Orca Bio
Sacramento, CA
17h ago
$75K - $95K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Breast Cancer(582)Prostate Cancer(389)Non-small Cell Lung Cancer(388)Multiple Myeloma(362)Cancer(251)Advanced Solid Tumors(229)Acute Myeloid Leukemia(210)Neoplasms(203)Colorectal Cancer(172)Melanoma(170)